Five Questions for Monica Gandhi
Monica Gandhi, MD, MPH, an infectious disease expert and professor of medicine, has been an ardent voice for science during the coronavirus pandemic.
University of California San Francisco
Give to UCSF
An All-Out Quest to Understand Long COVID
A concerted research effort gave UCSF scientists early insight into long COVID. It also showed patients that they weren’t in the fight alone.
COVID Patients on SSRI Antidepressants Are Less Likely to Die, UCSF-Stanford Study Finds
A UCSF and Stanford study of electronic health records linked SSRIs, the most widely prescribed antidepressants, to survival for COVID-19 patients.
Newly Discovered Skin Cell May Underlie Inflammatory Skin Disease
UCSF researchers have discovered a new type of cell that may be responsible for the exaggerated immune response behind inflammatory disease.
UCSF Rises in US News Global Universities Rankings for 2022
UCSF’s research has been ranked among the top in the world, according to the latest U.S. News & World Report’s Best Global Universities 2022 rankings.
3 Teens with COVID-19 Developed Sudden Severe Psychiatric Symptoms. Why?
Three adolescents who had mild or asymptomatic COVID-19 developed sudden severe psychiatric symptoms. A recent study into their immune responses identifies a potential mechanism by which these symptoms emerge.
Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People With HIV
A groundbreaking national study led by UCSF finds that treating anal cancer precursor lesions reduces cancer risk for people with HIV.
Exposure to Abuse, Violence Leaves an Immune Signature
Trauma leaves marks on the body, as well as the mind. UCSF scientists have identified an immune signature to indicate which patients will respond best to therapy.
Community-Based Strategy Succeeds in Vaccinating Latinx San Franciscans
A community-based effort to overcome vaccine hesitancy designed by UCSF scientists working together with San Francisco’s Latino Task Force is succeeding in the Mission District of San Francisco.
Data-Driven Drug Dosing Speeds Tuberculosis Treatment to 4 Months
A clinical trial of new treatment regimens, led in part by researchers at UCSF, recently demonstrated that a more potent combination of antibiotics could shorten the duration of treatment for TB.
COVID-19 Vaccines Produce Immune Responses in Patients With Chronic Inflammatory Diseases
Most patients on immunosuppressive drugs for chronic inflammatory conditions, like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease, can still produce antibodies after receiving the mRNA COVID-19 vaccines, researchers at UCSF and Washington University have concluded.
COVID-19 During Pregnancy Associated with Preterm Birth
Individuals who contract COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth.
How Dangerous Is the Delta Variant? Here’s What the Science Says
We spoke to UCSF virologist Nadia Roan, PhD, about the latest developments in our knowledge of the Delta variant, including how the new variant spreads so efficiently, whether it causes more serious illness, and why she thinks vaccines will hold the line.
UCSF to House COVID Tracking Project, a National Database Donated by The Atlantic
UCSF and The Atlantic have announced that the crowdsourced digital archive documenting the face of the pandemic in the United States will become part of the University’s permanent library collection and is accessible to researchers and the public.
